Copeptin does not accurately predict disease severity in imported malaria

Area of Science:

• Infectious Diseases
• Biomarker Discovery
• Clinical Diagnostics

Background:

• Copeptin, a stable marker for arginine vasopressin (AVP), correlates with disease severity in infections like leptospirosis and sepsis.
• Hyponatremia is frequent in severe imported malaria, suggesting AVP dysregulation.
• This study investigated copeptin's utility in predicting imported malaria severity.

Purpose of the Study:

• To evaluate copeptin as a predictor of disease severity in imported malaria.
• To compare copeptin's diagnostic performance against established biomarkers.

Main Methods:

• Copeptin levels were measured in serum samples from 204 imported malaria patients.
• The primary endpoint was the occurrence of World Health Organization-defined severe malaria.
• Diagnostic performance was compared to C-reactive protein, procalcitonin, lactate, and sodium.

Main Results:

• Of 204 patients, 25 developed severe malaria.
• Copeptin's Area Under the ROC curve (0.66) was comparable to lactate, sodium, and procalcitonin.
• C-reactive protein demonstrated superior performance (0.84) in predicting severe malaria.

Conclusions:

• C-reactive protein is an accurate predictor of severe imported malaria.
• Copeptin is not a reliable biomarker for severe malaria.
• Copeptin's clinical utility is limited to potentially excluding severe malaria cases.